Judge Sides With FDA Over Removing Zepbound From Shortage List
As Stat reports, the federal judge's ruling means patients will lose access to less-expensive versions of Eli Lilly's weight loss drug, as well as diabetes treatment Mounjaro, from compounding pharmacies. Also in industry news: Hims & Hers Health, the Lorna Breen Act, medtech innovations, and more.